Tag: prostate

The last decade has brought major advances in the way we diagnose and treat prostate cancer and men with advanced disease are living longer than ever. We spoke to our scientists about the most exciting research areas that have the potential to revolutionize prostate cancer treatment in years to come. About 1 in 8 men

The last decade has brought major advances in the way we diagnose and treat prostate cancer and men with advanced disease are living longer than ever. We spoke to our scientists about the most exciting research areas that have the potential to revolutionize prostate cancer treatment in years to come. About 1 in 8 men

In a large study led by Yale Cancer Center, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force (USPSTF) on screening. The results also showed significant increases in PSA testing among older men, a group for whom screening is

The risk of prostate cancer was 24% higher among 9/11 rescue and recovery workers after the attacks on the World Trade Center in 2001, with the highest risk among the earliest responders, finds research published online in the journal Occupational & Environmental Medicine. The findings indicate a shorter latency period from occupational exposure to disease

Most countries have not introduced nationwide prostate-cancer screening, as current methods result in overdiagnoses and excessive and unnecessary biopsies. A new study by researchers at Karolinska Institutet in Sweden, which is published in The New England Journal of Medicine, indicates that screening by magnetic resonance imaging (MRI) and targeted biopsies could potentially cut overdiagnoses by

Prostate cancer is the most common form of cancer among Canadian men and the third leading cause of cancer death. Abdominal obesity appears to be associated with a greater risk of developing aggressive prostate cancer. This link was demonstrated in a study led by Professor Marie-Élise Parent of Institut national de la recherche scientifique (INRS)

New research from CU Cancer Center member Scott Cramer, Ph.D., and his colleagues could help in the treatment of men with certain aggressive types of prostate cancer. Published this week in the journal Molecular Cancer Research, Cramer’s study specifically looks at how the loss of two specific prostate tumor-suppressing genes—MAP3K7 and CHD1 —increases androgen receptor

Widely used medications for benign prostatic hyperplasia (BPH)—also known as enlarged prostate—may be associated with a small, but significant increase in the probability of developing heart failure, suggests a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). The risk is highest in men taking a type of BPH medication

The prostate gland is a small gland that lies beneath the urinary bladder and in front of the rectum in males. The gland surrounds the top end of the urethra which carries urine from the bladder out of the body via the penis. The gland's size may vary with age. It is around the size

A less-invasive treatment technique called hemi-gland cryoablation (HGCryo)—destroying the areas of the prostate where cancers are located by freezing them—provides a high rate of effective prostate cancer control, according to a new study published in The Journal of Urology, Official Journal of the American Urological Association (AUA). “Freedom from cancer, as documented by biopsy, was

New blood test for prostate cancer could help monitor patients without invasive procedure and would reveal if they need urgent treatment Prostate cancer is most common among UK men with 50,000 diagnosed a year Study published in Journal of Clinical Investigation offers hope of a blood test At present the cancer is diagnosed through physical

Prostate cancer is the most common noncutaneous malignancy in the United States and is responsible for many male deaths. The development of prostate carcinogenesis is initially androgen-dependent. However, the progression of castration-resistant prostate cancer (CRPC) following androgen deprivation therapy is a major clinical problem. Although enzalutamide and abiraterone have been approved for CRPC hormone therapy,

A new study looks to move doctors and patients closer to earlier and more precise detection of recurrent prostate cancer that would clarify treatment decisions and lead to more confident courses of action and better health outcomes. A multi-center trial registry testing the use of a new imaging tracer—prostate specific membrane antigen (PSMA) – is

Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment. But those so-called antiandrogens also might put them at risk for a deadly heart condition, according to new research. In a study published Monday in the American Heart Association journal Circulation, researchers looked at how several testosterone-blocking drugs affect

Hormone therapy for prostate cancer increases risk of DEMENTIA by 20%, study finds The large study in the US looked at nearly 155,000 men with an average age of 74  It found those given the therapy had a 20% increased risk of any type of dementia  A hormone therapy used to treat prostate cancer in men

An innovative new digital model of follow-up care for prostate cancer allows patients to see test results online as soon as they become available, after a report was published in BMC Cancer. Researchers from the University of Southampton, funded by the Movember Foundation and delivered in partnership with Prostate Cancer UK, trialled the True NTH

Researchers in New York have found that treating human prostate cancer cells with a drug that targets a protein called PHLPP2 may prevent the cancer cells from spreading to other organs in the body. The study, which will be published May 15 in the Journal of Cell Biology, reveals that inhibiting PHLPP2 lowered the levels

A study published recently in the Journal of Clinical Oncology Precision Oncology, an American Society of Clinical Oncology (ASCO) journal, outlines findings from the largest-ever prospective genomic analysis of advanced prostate cancer tumors. Using comprehensive genomic profiling (CGP) to analyze thousands of tumor samples from men with advanced prostate cancers, the researchers identified that 57

Scientists have identified a gene mutation in the tumours of men with prostate cancer that is linked to very poor survival—and which could be used to pick out patients for more intensive treatment. Men with mutations in the retinoblastoma gene in their tumours were more than three times as likely to die and nearly seven

Prostate cancer and death rates have plummeted worldwide, study reveals About one in nine men develop prostate cancer over the course of their lives  In 1994, a blood test for the cancer was approved by the FDA  But the test led to over-diagnosis and has fallen out of favor  In 44 countries, prostate cancer rates